ZP2 inhibitors belong to a distinctive chemical class designed to modulate the activity of zona pellucida glycoprotein 2 (ZP2), a crucial player in the process of fertilization. ZP2 is a component of the extracellular matrix surrounding the oocyte, forming a protective layer known as the zona pellucida. This glycoprotein plays a pivotal role in mediating sperm-egg interactions during fertilization. ZP2 inhibitors, by definition, are compounds specifically designed to interfere with or regulate the function of ZP2.The development of ZP2 inhibitors stems from a deep understanding of the molecular mechanisms underlying fertilization. These inhibitors are meticulously designed molecules that target the ZP2 protein, aiming to modulate its activity without affecting other essential cellular processes.
Researchers have focused on unraveling the intricate structural details of ZP2 and identifying key binding sites that can be targeted by inhibitors. The rational design of these compounds involves a combination of computational modeling, structural biology techniques, and medicinal chemistry principles to ensure the specificity and efficacy of ZP2 inhibition. As the exploration of ZP2 inhibitors progresses, it contributes not only to the advancement of reproductive biology but also holds potential implications for understanding fundamental cellular interactions involved in fertilization. The ongoing research in this chemical class opens new avenues for manipulating the intricacies of reproductive processes, offering insights into the molecular events that underlie successful fertilization.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen can indirectly inhibit ZP2 by modulating estrogen receptor signaling, which is known to have a role in ZP2 expression and function. | ||||||
ICI 182,780 | 129453-61-8 | sc-203435 sc-203435A | 1 mg 10 mg | $83.00 $187.00 | 34 | |
Fulvestrant can act as an estrogen receptor antagonist, indirectly affecting ZP2 protein expression. | ||||||
Letrozole | 112809-51-5 | sc-204791 sc-204791A | 25 mg 50 mg | $87.00 $147.00 | 5 | |
Letrozole inhibits aromatase, an enzyme critical for estrogen production. This can indirectly affect the ZP2 protein. | ||||||
Anastrozole | 120511-73-1 | sc-217647 | 10 mg | $92.00 | 1 | |
Anastrozole can inhibit ZP2 indirectly through aromatase inhibition, affecting estrogen levels and subsequently ZP2 expression. | ||||||
Exemestane | 107868-30-4 | sc-203045 sc-203045A | 25 mg 100 mg | $134.00 $411.00 | ||
Exemestane can affect ZP2 indirectly by inhibiting aromatase, thereby affecting estrogen levels and ZP2 expression. | ||||||
Toremifene citrate | 89778-27-8 | sc-253712 | 100 mg | $100.00 | 3 | |
Toremifene can indirectly inhibit ZP2 by modulating estrogen receptor signaling, which affects ZP2 expression. | ||||||
Raloxifene | 84449-90-1 | sc-476458 | 1 g | $802.00 | 3 | |
Raloxifene can indirectly inhibit ZP2 by modulating estrogen receptor signaling, impacting ZP2 expression. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
Mifepristone can indirectly inhibit ZP2 by acting as a progesterone receptor antagonist, which may affect ZP2 expression. | ||||||
Levonorgestrel | 797-63-7 | sc-205731 sc-205731A | 100 mg 500 mg | $44.00 $198.00 | 1 | |
Levonorgestrel can indirectly inhibit ZP2 function by acting as a progesterone receptor modulator. | ||||||
Danazol | 17230-88-5 | sc-203021 sc-203021A | 100 mg 250 mg | $92.00 $238.00 | 3 | |
Danazol can inhibit ZP2 indirectly through suppressing the pituitary-ovarian axis, affecting hormone levels that influence ZP2 expression. | ||||||